nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—ABCB4—bile duct—hepatitis B	0.199	0.725	CbGeAlD
Etravirine—Infection mixed—Entecavir—hepatitis B	0.08	0.113	CcSEcCtD
Etravirine—Hepatitis B—Entecavir—hepatitis B	0.0413	0.0584	CcSEcCtD
Etravirine—Hepatitis B—Telbivudine—hepatitis B	0.0339	0.048	CcSEcCtD
Etravirine—Hepatitis C—Lamivudine—hepatitis B	0.0201	0.0285	CcSEcCtD
Etravirine—Hepatitis B—Lamivudine—hepatitis B	0.0191	0.0271	CcSEcCtD
Etravirine—Lipodystrophy—Lamivudine—hepatitis B	0.0191	0.0271	CcSEcCtD
Etravirine—Buffalo hump—Lamivudine—hepatitis B	0.0174	0.0246	CcSEcCtD
Etravirine—Lipodystrophy acquired—Lamivudine—hepatitis B	0.0167	0.0236	CcSEcCtD
Etravirine—Basedow's disease—Lamivudine—hepatitis B	0.016	0.0226	CcSEcCtD
Etravirine—Lipohypertrophy—Lamivudine—hepatitis B	0.016	0.0226	CcSEcCtD
Etravirine—ABCB4—blood—hepatitis B	0.016	0.058	CbGeAlD
Etravirine—Hypertrophy of breast—Lamivudine—hepatitis B	0.0148	0.021	CcSEcCtD
Etravirine—ABCB4—liver—hepatitis B	0.0125	0.0453	CbGeAlD
Etravirine—Hepatic steatosis—Lamivudine—hepatitis B	0.0116	0.0164	CcSEcCtD
Etravirine—Hepatomegaly—Entecavir—hepatitis B	0.0107	0.0151	CcSEcCtD
Etravirine—Autoimmune disorder—Lamivudine—hepatitis B	0.0105	0.0148	CcSEcCtD
Etravirine—CYP2C19—blood plasma—hepatitis B	0.0103	0.0373	CbGeAlD
Etravirine—Hepatomegaly—Telbivudine—hepatitis B	0.00875	0.0124	CcSEcCtD
Etravirine—Opportunistic infection—Lamivudine—hepatitis B	0.00866	0.0123	CcSEcCtD
Etravirine—CYP2C9—blood plasma—hepatitis B	0.00797	0.0289	CbGeAlD
Etravirine—Rhabdomyolysis—Telbivudine—hepatitis B	0.007	0.00991	CcSEcCtD
Etravirine—Hepatic failure—Entecavir—hepatitis B	0.00609	0.00862	CcSEcCtD
Etravirine—Hypertriglyceridaemia—Lamivudine—hepatitis B	0.00608	0.0086	CcSEcCtD
Etravirine—CYP3A4—blood plasma—hepatitis B	0.00608	0.0221	CbGeAlD
Etravirine—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.00594	0.00841	CcSEcCtD
Etravirine—ABCB4—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.00555	0.301	CbGpPWpGaD
Etravirine—Breast enlargement—Lamivudine—hepatitis B	0.00538	0.00762	CcSEcCtD
Etravirine—Blood triglycerides increased—Lamivudine—hepatitis B	0.00533	0.00754	CcSEcCtD
Etravirine—Hepatomegaly—Lamivudine—hepatitis B	0.00493	0.00698	CcSEcCtD
Etravirine—Pancreatitis—Entecavir—hepatitis B	0.00464	0.00656	CcSEcCtD
Etravirine—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00452	0.0064	CcSEcCtD
Etravirine—ABCB1—blood plasma—hepatitis B	0.0043	0.0156	CbGeAlD
Etravirine—Hyperglycaemia—Entecavir—hepatitis B	0.00427	0.00604	CcSEcCtD
Etravirine—Blood disorder—Lamivudine—hepatitis B	0.00418	0.00592	CcSEcCtD
Etravirine—Renal failure—Entecavir—hepatitis B	0.00415	0.00587	CcSEcCtD
Etravirine—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00404	0.00573	CcSEcCtD
Etravirine—Hepatobiliary disease—Entecavir—hepatitis B	0.00399	0.00565	CcSEcCtD
Etravirine—Gastritis—Telbivudine—hepatitis B	0.00398	0.00563	CcSEcCtD
Etravirine—Rhabdomyolysis—Lamivudine—hepatitis B	0.00394	0.00558	CcSEcCtD
Etravirine—Abdominal distension—Telbivudine—hepatitis B	0.00391	0.00554	CcSEcCtD
Etravirine—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00389	0.00551	CcSEcCtD
Etravirine—Hepatitis—Entecavir—hepatitis B	0.00379	0.00536	CcSEcCtD
Etravirine—CYP2C19—blood—hepatitis B	0.00376	0.0137	CbGeAlD
Etravirine—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00369	0.00523	CcSEcCtD
Etravirine—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00369	0.00522	CcSEcCtD
Etravirine—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00365	0.00516	CcSEcCtD
Etravirine—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00363	0.00514	CcSEcCtD
Etravirine—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00362	0.00513	CcSEcCtD
Etravirine—Inflammation—Lamivudine—hepatitis B	0.0036	0.00509	CcSEcCtD
Etravirine—Immune system disorder—Entecavir—hepatitis B	0.00342	0.00484	CcSEcCtD
Etravirine—Renal failure—Telbivudine—hepatitis B	0.00341	0.00482	CcSEcCtD
Etravirine—Neuropathy peripheral—Telbivudine—hepatitis B	0.0034	0.00481	CcSEcCtD
Etravirine—Mental disorder—Entecavir—hepatitis B	0.00332	0.0047	CcSEcCtD
Etravirine—Malnutrition—Entecavir—hepatitis B	0.0033	0.00467	CcSEcCtD
Etravirine—Hepatobiliary disease—Telbivudine—hepatitis B	0.00328	0.00464	CcSEcCtD
Etravirine—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00322	0.00455	CcSEcCtD
Etravirine—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00317	0.00449	CcSEcCtD
Etravirine—Gynaecomastia—Lamivudine—hepatitis B	0.00312	0.00442	CcSEcCtD
Etravirine—Hepatitis—Telbivudine—hepatitis B	0.00311	0.0044	CcSEcCtD
Etravirine—Hypoaesthesia—Telbivudine—hepatitis B	0.00309	0.00438	CcSEcCtD
Etravirine—Connective tissue disorder—Telbivudine—hepatitis B	0.00306	0.00433	CcSEcCtD
Etravirine—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00297	0.00421	CcSEcCtD
Etravirine—CYP2C19—liver—hepatitis B	0.00294	0.0107	CbGeAlD
Etravirine—Sleep disorder—Lamivudine—hepatitis B	0.00293	0.00414	CcSEcCtD
Etravirine—CYP2C9—blood—hepatitis B	0.00292	0.0106	CbGeAlD
Etravirine—Mediastinal disorder—Telbivudine—hepatitis B	0.0028	0.00397	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00279	0.00394	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00272	0.00385	CcSEcCtD
Etravirine—Malnutrition—Telbivudine—hepatitis B	0.00271	0.00383	CcSEcCtD
Etravirine—Infection—Entecavir—hepatitis B	0.00267	0.00378	CcSEcCtD
Etravirine—Nervous system disorder—Entecavir—hepatitis B	0.00264	0.00373	CcSEcCtD
Etravirine—Skin disorder—Entecavir—hepatitis B	0.00261	0.0037	CcSEcCtD
Etravirine—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00257	0.00364	CcSEcCtD
Etravirine—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00257	0.00364	CcSEcCtD
Etravirine—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00255	0.00361	CcSEcCtD
Etravirine—Ill-defined disorder—Telbivudine—hepatitis B	0.00251	0.00356	CcSEcCtD
Etravirine—Anorexia—Adefovir Dipivoxil—hepatitis B	0.0025	0.00354	CcSEcCtD
Etravirine—Malaise—Telbivudine—hepatitis B	0.00244	0.00346	CcSEcCtD
Etravirine—Insomnia—Entecavir—hepatitis B	0.00243	0.00344	CcSEcCtD
Etravirine—Somnolence—Entecavir—hepatitis B	0.00239	0.00338	CcSEcCtD
Etravirine—Gastrointestinal disorder—Entecavir—hepatitis B	0.00232	0.00329	CcSEcCtD
Etravirine—Fatigue—Entecavir—hepatitis B	0.00232	0.00328	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00229	0.00324	CcSEcCtD
Etravirine—CYP2C9—liver—hepatitis B	0.00228	0.00829	CbGeAlD
Etravirine—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00228	0.00323	CcSEcCtD
Etravirine—Discomfort—Telbivudine—hepatitis B	0.00228	0.00322	CcSEcCtD
Etravirine—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00227	0.00321	CcSEcCtD
Etravirine—CYP3A4—blood—hepatitis B	0.00223	0.00809	CbGeAlD
Etravirine—Abdominal distension—Lamivudine—hepatitis B	0.0022	0.00312	CcSEcCtD
Etravirine—Gastrointestinal pain—Entecavir—hepatitis B	0.0022	0.00311	CcSEcCtD
Etravirine—Nervous system disorder—Telbivudine—hepatitis B	0.00217	0.00307	CcSEcCtD
Etravirine—Thrombocytopenia—Telbivudine—hepatitis B	0.00216	0.00306	CcSEcCtD
Etravirine—Pancreatitis—Lamivudine—hepatitis B	0.00215	0.00304	CcSEcCtD
Etravirine—Skin disorder—Telbivudine—hepatitis B	0.00215	0.00304	CcSEcCtD
Etravirine—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00215	0.00304	CcSEcCtD
Etravirine—Abdominal pain—Entecavir—hepatitis B	0.00213	0.00301	CcSEcCtD
Etravirine—Body temperature increased—Entecavir—hepatitis B	0.00213	0.00301	CcSEcCtD
Etravirine—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00207	0.00294	CcSEcCtD
Etravirine—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00207	0.00294	CcSEcCtD
Etravirine—Insomnia—Telbivudine—hepatitis B	0.002	0.00283	CcSEcCtD
Etravirine—Paraesthesia—Telbivudine—hepatitis B	0.00198	0.00281	CcSEcCtD
Etravirine—Hyperglycaemia—Lamivudine—hepatitis B	0.00198	0.0028	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00194	0.00274	CcSEcCtD
Etravirine—Asthenia—Entecavir—hepatitis B	0.00193	0.00273	CcSEcCtD
Etravirine—Renal failure—Lamivudine—hepatitis B	0.00192	0.00272	CcSEcCtD
Etravirine—Neuropathy peripheral—Lamivudine—hepatitis B	0.00191	0.00271	CcSEcCtD
Etravirine—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00191	0.0027	CcSEcCtD
Etravirine—Fatigue—Telbivudine—hepatitis B	0.0019	0.0027	CcSEcCtD
Etravirine—Stomatitis—Lamivudine—hepatitis B	0.0019	0.00269	CcSEcCtD
Etravirine—Pain—Telbivudine—hepatitis B	0.00189	0.00267	CcSEcCtD
Etravirine—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00188	0.00267	CcSEcCtD
Etravirine—Hepatobiliary disease—Lamivudine—hepatitis B	0.00185	0.00261	CcSEcCtD
Etravirine—Diarrhoea—Entecavir—hepatitis B	0.00184	0.00261	CcSEcCtD
Etravirine—Feeling abnormal—Telbivudine—hepatitis B	0.00182	0.00258	CcSEcCtD
Etravirine—Gastrointestinal pain—Telbivudine—hepatitis B	0.00181	0.00256	CcSEcCtD
Etravirine—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.0018	0.00254	CcSEcCtD
Etravirine—Dizziness—Entecavir—hepatitis B	0.00178	0.00252	CcSEcCtD
Etravirine—Hepatitis—Lamivudine—hepatitis B	0.00175	0.00248	CcSEcCtD
Etravirine—Body temperature increased—Telbivudine—hepatitis B	0.00175	0.00247	CcSEcCtD
Etravirine—Abdominal pain—Telbivudine—hepatitis B	0.00175	0.00247	CcSEcCtD
Etravirine—Hypoaesthesia—Lamivudine—hepatitis B	0.00174	0.00247	CcSEcCtD
Etravirine—CYP3A4—liver—hepatitis B	0.00174	0.00632	CbGeAlD
Etravirine—Connective tissue disorder—Lamivudine—hepatitis B	0.00172	0.00244	CcSEcCtD
Etravirine—Vomiting—Entecavir—hepatitis B	0.00171	0.00242	CcSEcCtD
Etravirine—Rash—Entecavir—hepatitis B	0.0017	0.0024	CcSEcCtD
Etravirine—Dermatitis—Entecavir—hepatitis B	0.00169	0.0024	CcSEcCtD
Etravirine—Headache—Entecavir—hepatitis B	0.00168	0.00239	CcSEcCtD
Etravirine—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00167	0.00236	CcSEcCtD
Etravirine—Erythema multiforme—Lamivudine—hepatitis B	0.00166	0.00235	CcSEcCtD
Etravirine—Rash—Adefovir Dipivoxil—hepatitis B	0.00165	0.00234	CcSEcCtD
Etravirine—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00165	0.00234	CcSEcCtD
Etravirine—Headache—Adefovir Dipivoxil—hepatitis B	0.00164	0.00233	CcSEcCtD
Etravirine—Nausea—Entecavir—hepatitis B	0.0016	0.00226	CcSEcCtD
Etravirine—Asthenia—Telbivudine—hepatitis B	0.00159	0.00224	CcSEcCtD
Etravirine—Immune system disorder—Lamivudine—hepatitis B	0.00158	0.00224	CcSEcCtD
Etravirine—Mediastinal disorder—Lamivudine—hepatitis B	0.00158	0.00224	CcSEcCtD
Etravirine—ABCB1—blood—hepatitis B	0.00158	0.00572	CbGeAlD
Etravirine—Nausea—Adefovir Dipivoxil—hepatitis B	0.00156	0.00221	CcSEcCtD
Etravirine—Malnutrition—Lamivudine—hepatitis B	0.00153	0.00216	CcSEcCtD
Etravirine—Diarrhoea—Telbivudine—hepatitis B	0.00151	0.00214	CcSEcCtD
Etravirine—Flatulence—Lamivudine—hepatitis B	0.0015	0.00213	CcSEcCtD
Etravirine—Tension—Lamivudine—hepatitis B	0.0015	0.00212	CcSEcCtD
Etravirine—Nervousness—Lamivudine—hepatitis B	0.00148	0.0021	CcSEcCtD
Etravirine—Dizziness—Telbivudine—hepatitis B	0.00146	0.00207	CcSEcCtD
Etravirine—Tremor—Lamivudine—hepatitis B	0.00143	0.00202	CcSEcCtD
Etravirine—Ill-defined disorder—Lamivudine—hepatitis B	0.00142	0.002	CcSEcCtD
Etravirine—Anaemia—Lamivudine—hepatitis B	0.00141	0.002	CcSEcCtD
Etravirine—Vomiting—Telbivudine—hepatitis B	0.0014	0.00199	CcSEcCtD
Etravirine—Angioedema—Lamivudine—hepatitis B	0.00139	0.00197	CcSEcCtD
Etravirine—Rash—Telbivudine—hepatitis B	0.00139	0.00197	CcSEcCtD
Etravirine—Dermatitis—Telbivudine—hepatitis B	0.00139	0.00197	CcSEcCtD
Etravirine—Headache—Telbivudine—hepatitis B	0.00138	0.00196	CcSEcCtD
Etravirine—Malaise—Lamivudine—hepatitis B	0.00138	0.00195	CcSEcCtD
Etravirine—Vertigo—Lamivudine—hepatitis B	0.00137	0.00194	CcSEcCtD
Etravirine—Syncope—Lamivudine—hepatitis B	0.00137	0.00194	CcSEcCtD
Etravirine—Loss of consciousness—Lamivudine—hepatitis B	0.00134	0.0019	CcSEcCtD
Etravirine—Convulsion—Lamivudine—hepatitis B	0.00132	0.00187	CcSEcCtD
Etravirine—Nausea—Telbivudine—hepatitis B	0.00131	0.00186	CcSEcCtD
Etravirine—Anxiety—Lamivudine—hepatitis B	0.00129	0.00183	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00129	0.00183	CcSEcCtD
Etravirine—Discomfort—Lamivudine—hepatitis B	0.00128	0.00182	CcSEcCtD
Etravirine—Dry mouth—Lamivudine—hepatitis B	0.00127	0.0018	CcSEcCtD
Etravirine—Confusional state—Lamivudine—hepatitis B	0.00126	0.00178	CcSEcCtD
Etravirine—Infection—Lamivudine—hepatitis B	0.00124	0.00175	CcSEcCtD
Etravirine—ABCB1—liver—hepatitis B	0.00123	0.00448	CbGeAlD
Etravirine—Shock—Lamivudine—hepatitis B	0.00122	0.00173	CcSEcCtD
Etravirine—Nervous system disorder—Lamivudine—hepatitis B	0.00122	0.00173	CcSEcCtD
Etravirine—Thrombocytopenia—Lamivudine—hepatitis B	0.00122	0.00173	CcSEcCtD
Etravirine—Skin disorder—Lamivudine—hepatitis B	0.00121	0.00171	CcSEcCtD
Etravirine—Hyperhidrosis—Lamivudine—hepatitis B	0.0012	0.0017	CcSEcCtD
Etravirine—Anorexia—Lamivudine—hepatitis B	0.00119	0.00168	CcSEcCtD
Etravirine—Insomnia—Lamivudine—hepatitis B	0.00113	0.00159	CcSEcCtD
Etravirine—Paraesthesia—Lamivudine—hepatitis B	0.00112	0.00158	CcSEcCtD
Etravirine—Somnolence—Lamivudine—hepatitis B	0.00111	0.00157	CcSEcCtD
Etravirine—Decreased appetite—Lamivudine—hepatitis B	0.00108	0.00153	CcSEcCtD
Etravirine—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00107	0.00152	CcSEcCtD
Etravirine—Fatigue—Lamivudine—hepatitis B	0.00107	0.00152	CcSEcCtD
Etravirine—Pain—Lamivudine—hepatitis B	0.00106	0.00151	CcSEcCtD
Etravirine—Constipation—Lamivudine—hepatitis B	0.00106	0.00151	CcSEcCtD
Etravirine—Feeling abnormal—Lamivudine—hepatitis B	0.00103	0.00145	CcSEcCtD
Etravirine—Gastrointestinal pain—Lamivudine—hepatitis B	0.00102	0.00144	CcSEcCtD
Etravirine—Abdominal pain—Lamivudine—hepatitis B	0.000984	0.00139	CcSEcCtD
Etravirine—Body temperature increased—Lamivudine—hepatitis B	0.000984	0.00139	CcSEcCtD
Etravirine—Hypersensitivity—Lamivudine—hepatitis B	0.000917	0.0013	CcSEcCtD
Etravirine—Asthenia—Lamivudine—hepatitis B	0.000893	0.00126	CcSEcCtD
Etravirine—Diarrhoea—Lamivudine—hepatitis B	0.000852	0.00121	CcSEcCtD
Etravirine—Dizziness—Lamivudine—hepatitis B	0.000823	0.00117	CcSEcCtD
Etravirine—Vomiting—Lamivudine—hepatitis B	0.000792	0.00112	CcSEcCtD
Etravirine—Rash—Lamivudine—hepatitis B	0.000785	0.00111	CcSEcCtD
Etravirine—Dermatitis—Lamivudine—hepatitis B	0.000784	0.00111	CcSEcCtD
Etravirine—Headache—Lamivudine—hepatitis B	0.00078	0.0011	CcSEcCtD
Etravirine—Nausea—Lamivudine—hepatitis B	0.00074	0.00105	CcSEcCtD
Etravirine—CYP2C19—CYP2E1 reactions—CYP2A6—hepatitis B	0.000738	0.04	CbGpPWpGaD
Etravirine—CYP2C9—CYP2E1 reactions—CYP2A6—hepatitis B	0.000673	0.0365	CbGpPWpGaD
Etravirine—CYP3A4—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.000473	0.0256	CbGpPWpGaD
Etravirine—CYP2C19—Xenobiotics—CYP2A6—hepatitis B	0.000458	0.0248	CbGpPWpGaD
Etravirine—CYP2C19—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00044	0.0238	CbGpPWpGaD
Etravirine—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.00044	0.0238	CbGpPWpGaD
Etravirine—CYP2C9—Xenobiotics—CYP2A6—hepatitis B	0.000417	0.0226	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00041	0.0222	CbGpPWpGaD
Etravirine—CYP2C9—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000401	0.0217	CbGpPWpGaD
Etravirine—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.000329	0.0178	CbGpPWpGaD
Etravirine—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000314	0.017	CbGpPWpGaD
Etravirine—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000307	0.0166	CbGpPWpGaD
Etravirine—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000286	0.0155	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—HLA-DPA1—hepatitis B	0.000283	0.0153	CbGpPWpGaD
Etravirine—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	0.000275	0.0149	CbGpPWpGaD
Etravirine—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000265	0.0143	CbGpPWpGaD
Etravirine—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.000224	0.0121	CbGpPWpGaD
Etravirine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00019	0.0103	CbGpPWpGaD
Etravirine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000189	0.0102	CbGpPWpGaD
Etravirine—CYP2C19—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000187	0.0102	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000186	0.0101	CbGpPWpGaD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—HNF4A—hepatitis B	0.000183	0.0099	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—AKR1B1—hepatitis B	0.000183	0.0099	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—GGT2—hepatitis B	0.000175	0.00949	CbGpPWpGaD
Etravirine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000173	0.00939	CbGpPWpGaD
Etravirine—CYP2C19—Arachidonic acid metabolism—GGT1—hepatitis B	0.000172	0.0093	CbGpPWpGaD
Etravirine—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000171	0.00926	CbGpPWpGaD
Etravirine—CYP2C9—Arachidonic acid metabolism—GGT1—hepatitis B	0.000156	0.00848	CbGpPWpGaD
Etravirine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000154	0.00835	CbGpPWpGaD
Etravirine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00014	0.00761	CbGpPWpGaD
Etravirine—CYP2C19—Metapathway biotransformation—AKR1B1—hepatitis B	0.000139	0.00753	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—GGT2—hepatitis B	0.000135	0.00732	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—HLA-DPB1—hepatitis B	0.00013	0.00705	CbGpPWpGaD
Etravirine—CYP2C9—Metapathway biotransformation—AKR1B1—hepatitis B	0.000127	0.00686	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—GGT2—hepatitis B	0.000123	0.00667	CbGpPWpGaD
Etravirine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000114	0.00619	CbGpPWpGaD
Etravirine—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000113	0.00611	CbGpPWpGaD
Etravirine—CYP2C19—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000107	0.00581	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—CYP2A6—hepatitis B	0.000106	0.00575	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—ALB—hepatitis B	9.9e-05	0.00536	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—GOT2—hepatitis B	9.6e-05	0.0052	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—CD40LG—hepatitis B	9.59e-05	0.0052	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—IL10—hepatitis B	9.59e-05	0.0052	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	9.26e-05	0.00502	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—FASLG—hepatitis B	8.91e-05	0.00483	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—FAS—hepatitis B	8.6e-05	0.00466	CbGpPWpGaD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—NOS2—hepatitis B	8.49e-05	0.0046	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—HLA-A—hepatitis B	8.45e-05	0.00458	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	8.35e-05	0.00453	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—GOT1—hepatitis B	8.29e-05	0.00449	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—GGT1—hepatitis B	8.29e-05	0.00449	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—CYP2A6—hepatitis B	8.18e-05	0.00443	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—GGT2—hepatitis B	8.12e-05	0.0044	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	7.81e-05	0.00423	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—HLA-DRB1—hepatitis B	7.72e-05	0.00418	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	7.55e-05	0.00409	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—CYP2A6—hepatitis B	7.46e-05	0.00404	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—GGT1—hepatitis B	6.39e-05	0.00346	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—GGT1—hepatitis B	5.82e-05	0.00316	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—IFNG—hepatitis B	5.64e-05	0.00306	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	5.41e-05	0.00293	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—IL2—hepatitis B	5.01e-05	0.00272	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	4.93e-05	0.00267	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	4.92e-05	0.00267	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—ALB—hepatitis B	4.41e-05	0.00239	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	4.4e-05	0.00238	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	4.24e-05	0.0023	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—TGFB1—hepatitis B	3.91e-05	0.00212	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—GGT1—hepatitis B	3.84e-05	0.00208	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—TNF—hepatitis B	3.65e-05	0.00198	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PTEN—hepatitis B	3.36e-05	0.00182	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	2.45e-05	0.00133	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—AKR1B1—hepatitis B	2.41e-05	0.00131	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	2.39e-05	0.00129	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—AKR1B1—hepatitis B	2.35e-05	0.00127	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	2.33e-05	0.00126	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	2.33e-05	0.00126	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	2.32e-05	0.00125	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GGT2—hepatitis B	2.31e-05	0.00125	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GGT2—hepatitis B	2.25e-05	0.00122	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	2.24e-05	0.00121	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—AKR1B1—hepatitis B	2.2e-05	0.00119	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GGT2—hepatitis B	2.11e-05	0.00114	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	1.93e-05	0.00105	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	1.8e-05	0.000976	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	1.59e-05	0.00086	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—AKR1B1—hepatitis B	1.45e-05	0.000785	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP2A6—hepatitis B	1.4e-05	0.000758	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GGT2—hepatitis B	1.39e-05	0.000753	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP2A6—hepatitis B	1.37e-05	0.00074	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.3e-05	0.000707	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP2A6—hepatitis B	1.28e-05	0.000691	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GOT2—hepatitis B	1.27e-05	0.000686	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GOT2—hepatitis B	1.23e-05	0.000669	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	1.21e-05	0.000656	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.19e-05	0.000645	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GOT2—hepatitis B	1.15e-05	0.000625	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GGT1—hepatitis B	1.09e-05	0.000592	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GOT1—hepatitis B	1.09e-05	0.000592	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GOT1—hepatitis B	1.07e-05	0.000578	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GGT1—hepatitis B	1.07e-05	0.000578	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GGT1—hepatitis B	9.96e-06	0.00054	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GOT1—hepatitis B	9.96e-06	0.00054	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	9.95e-06	0.000539	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	9.08e-06	0.000492	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP2A6—hepatitis B	8.41e-06	0.000456	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GOT2—hepatitis B	7.61e-06	0.000412	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GGT1—hepatitis B	6.57e-06	0.000356	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GOT1—hepatitis B	6.57e-06	0.000356	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALB—hepatitis B	5.81e-06	0.000315	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALB—hepatitis B	5.67e-06	0.000307	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALB—hepatitis B	5.3e-06	0.000287	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PTEN—hepatitis B	4.43e-06	0.00024	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PTEN—hepatitis B	4.33e-06	0.000234	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PTEN—hepatitis B	4.04e-06	0.000219	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALB—hepatitis B	3.49e-06	0.000189	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PTEN—hepatitis B	2.67e-06	0.000144	CbGpPWpGaD
